• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NextCure, Inc. - Common Stock (NQ:NXTC)

    11.70 +1.38 (+13.32%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 161,137
    Open 10.51
    Bid (Size) 11.00 (500)
    Ask (Size) 13.34 (200)
    Prev. Close 10.32
    Today's Range 10.51 - 13.29
    52wk Range 0.3412 - 15.74
    Shares Outstanding 2,676,110
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
    The American Society for Clinical Oncology to be held in Chicago May 29 – June 2, 2026 
    From NextCure
    Via GlobeNewswire

    Performance

    YTD
    -11.9%
    -11.9%
    1 Month
    +12.4%
    +12.4%
    3 Month
    -11.8%
    -11.8%
    6 Month
    +8.1%
    +8.1%
    1 Year
    +3070.7%
    +3070.7%

    More News

    Read More
    News headline image
    NextCure Provides Business Update and Reports Full Year 2025 Financial Results
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Provides Business Update
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From NextCure
    Via GlobeNewswire
    News headline image
    NextCure (NXTC) Q2 Loss Widens 71% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
    From NextCure
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    US Stocks Likely To Open On A Mixed Note: Intel, Philips 66, Centene, Charter Earnings In Focus ↗
    Via Benzinga
    News headline image
    Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment ↗
    Via Stocktwits
    News headline image
    Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Thursday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
    From NextCure
    Via GlobeNewswire
    News headline image
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline ↗
    Via Stocktwits
    News headline image
    NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
    From NextCure
    Via GlobeNewswire

    Frequently Asked Questions

    Is NextCure, Inc. - Common Stock publicly traded?
    Yes, NextCure, Inc. - Common Stock is publicly traded.
    What exchange does NextCure, Inc. - Common Stock trade on?
    NextCure, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NextCure, Inc. - Common Stock?
    The ticker symbol for NextCure, Inc. - Common Stock is NXTC on the Nasdaq Stock Market
    What is the current price of NextCure, Inc. - Common Stock?
    The current price of NextCure, Inc. - Common Stock is 11.70
    When was NextCure, Inc. - Common Stock last traded?
    The last trade of NextCure, Inc. - Common Stock was at 04/20/26 04:00 PM ET
    What is the market capitalization of NextCure, Inc. - Common Stock?
    The market capitalization of NextCure, Inc. - Common Stock is 31.31M
    How many shares of NextCure, Inc. - Common Stock are outstanding?
    NextCure, Inc. - Common Stock has 31M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.